Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 2350 of 3284 entries
View as:

Retrospective Study to Describe the Real-world Treatment Patterns and Associated Clinical Outcomes in Patients With Metastatic Castration-resistant Prostates Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04801186 Org: User:
Start: 09/28/21 End: 09/30/22 Due: 09/30/23

Positron Emission Tomography (PET) Study With (11C) Flumazenil to Determine Central GABAA Receptor Occupancy of AZD6280

Phase: N/A Priority: Normal
NCT ID: NCT00681746 Org: User:
Start: 02/29/08 End: 09/30/08 Due: 09/30/09

Descriptive Study in Patients Treated With Vimovo™, Including Registration of the Physicians' Prescribing Patterns

Phase: N/A Priority: Normal
NCT ID: NCT01511926 Org: User:
Start: 01/31/12 End: 03/31/14 Due: 03/31/15

A Descriptive Study to Explore Certain Characteristics of Patients at Risk for Chronic Obstructive Pulmonary Disease (COPD) in a Primary Care Setting

Phase: N/A Priority: Normal
NCT ID: NCT01013922 Org: User:
Start: 10/31/09 End: 03/31/10 Due: 03/31/11

Study to Assess the Metabolism, Excretion and Pharmacokinetics of [14C]AZD1981 in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01058447 Org: User:
Start: 02/28/10 End: 03/31/10 Due: 03/31/11

Safety Study of AZD5672 in Renally Impaired Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00715702 Org: User:
Start: 07/31/08 End: 02/28/09 Due: 02/28/10

A Study to Assess the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Multiple Ascending Doses of AZD5069 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01051505 Org: User:
Start: 01/31/10 End: 04/30/10 Due: 04/30/11

A Study of ZD1839 Effects on Cell Proliferation in Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00252811 Org: User:
Start: 02/29/04 End: - Due: -

Oxford/AstraZeneca COVID-19 Vaccine Effectiveness in England

Phase: N/A Priority: Normal
NCT ID: NCT05047822 Org: User:
Start: 08/23/21 End: 01/27/23 Due: 01/27/24

Gastroprotective Agent Utilization and Compliance in Elderly Patients Taking Non-steroidal Anti-inflammatory Drug (NSAID) in France

Phase: N/A Priority: Normal
NCT ID: NCT01211652 Org: User:
Start: 10/31/10 End: 11/30/10 Due: 11/30/11

Budesonide / Formoterol in Treatment of Exacerbations of COPD

Phase: N/A Priority: Normal
NCT ID: NCT00239278 Org: User:
Start: 01/31/01 End: 01/31/05 Due: 01/31/06

CHOICE: CHanges to Treatment and Outcomes in Patients With Type 2 Diabetes Initiating InjeCtablE Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00635492 Org: User:
Start: 01/31/08 End: 12/31/11 Due: 12/31/12

To Assess the Pharmacokinetics of AZD1656 and Its Metabolite in Type 2 Diabetes Mellitus Patients

Phase: N/A Priority: Normal
NCT ID: NCT01069926 Org: User:
Start: 03/31/10 End: 10/31/10 Due: 10/31/11

A Study to Evaluate the Effect of Budesonide, Glycopyrronium, Formoterol Fumarate (BGF) Metered Dose Inhaler (MDI), Budesonide and Formoterol Fumarate (BFF) MDI and Placebo MDI on Exercise Parameters in Participants With Chronic Obstructive Pulmonary Disease (COPD).

Phase: N/A Priority: Normal
NCT ID: NCT06067828 Org: User:
Start: 10/24/23 End: 08/25/25 Due: 08/25/26

Efficacy and Safety of SEROQUEL Extended Release (XR) in Acute Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT00954122 Org: User:
Start: 09/30/09 End: 04/30/10 Due: 04/30/11

An INternational Frontline Ovarian Cancer Real World Management Study

Phase: N/A Priority: Normal
NCT ID: NCT04460768 Org: User:
Start: 06/27/20 End: 11/10/20 Due: 11/10/21

ChAracterisation of ItaliaN Severe Uncontrolled Asthmatic patieNts Key Features When Receiving Benralizumab

Phase: N/A Priority: Normal
NCT ID: NCT04272463 Org: User:
Start: 03/13/20 End: 07/15/20 Due: 07/15/21

A Study to Evaluate the Disposition of Drug in Body and Safety After Administration of Single Inhaled Doses of Drugs Abediterol and AZD7594 Administered Alone, in Fixed Dose Combination and in Free Combination Using the Dry Powder Inhaler in Healthy Male Participants

Phase: N/A Priority: Normal
NCT ID: NCT02967159 Org: User:
Start: 11/24/16 End: 04/06/17 Due: 04/06/18

Quality of Life in Schizophrenic Patients

Phase: N/A Priority: Normal
NCT ID: NCT00597168 Org: User:
Start: 10/31/07 End: 10/31/09 Due: 10/31/10

Safety and Efficacy of Two Doses of Anifrolumab Compared to Placebo in Adult Subjects With Active Proliferative Lupus Nephritis

Phase: N/A Priority: Normal
NCT ID: NCT02547922 Org: User:
Start: 11/04/15 End: 01/18/21 Due: 01/18/22

An Efficacy and Safety Study of Lanabecestat (LY3314814) in Early Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT02245737 Org: User:
Start: 09/30/14 End: 10/04/18 Due: 10/04/19

Airway Clearance Study

Phase: N/A Priority: Normal
NCT ID: NCT00379028 Org: User:
Start: 09/30/06 End: 07/31/07 Due: 07/31/08

Investigate the Safety and Tolerability of AZD6244 Monotherapy or + Docetaxel in Japanese Patients With Advanced Solid Malignancies or Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01605916 Org: User:
Start: 06/30/12 End: 05/31/15 Due: 05/31/16

Phase I Safety and Tolerability Study of Cediranib (RECENTIN™, AZD2171) in Combination With Chemo in First Line Lung Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT00621361 Org: User:
Start: 02/29/08 End: 02/29/12 Due: 02/28/13

Study of Mental Care in Spain

Phase: N/A Priority: Normal
NCT ID: NCT00824031 Org: User:
Start: 01/31/09 End: 07/31/09 Due: 07/31/10